Qiagen NV | QIA - Gewinn Vor Steuern

Aktienkurs
28.59
Täglich Wechseln
0.24 0.85%
Monatlich
-19.71%
Jährlich
-23.99%
Q2 Prognose
27.51




Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
argenx SE USD 403.29M 17.24M 2025-12
Avita Medical AUD -11.64M 12.13M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Moderna USD -799M 612M 2025-12
Organon & Co USD -148M 391M 2025-12
Qiagen NV USD 109.17M 25.56M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -343M 335.1M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12